Kobayashi Pharmaceutical Co (FRA:KOY) Growth Rank: 4 (As of Sep. 05, 2026) — 43% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:KOY Kobayashi Pharmaceutical Co Ltd FRA:KOY
77 GF Score
Price €30.40
GF Value €26.16
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Kobayashi Pharmaceutical Co Growth Rank?

Kobayashi Pharmaceutical Co FRA:KOY +0.66% 77 Growth Rank is 4 as of Sep. 05, 2026, which is 43% below its 10-year median of 7.00. GuruFocus rates FRA:KOY with a GF Score™ of 77/100 and a GF Value™ of €26.16 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Kobayashi Pharmaceutical Co has the Growth Rank of 4.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Kobayashi Pharmaceutical Co Growth Rank Related Terms

FRA:KOY vs PG, CL, EL: Growth Rank Comparison

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kobayashi Pharmaceutical Co Growth Rank vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's Growth Rank distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's Growth Rank falls into.


FRA:KOY
77GF Score
Kobayashi Pharmaceutical Co Ltd FRA:KOY
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 4 mean?
Kobayashi Pharmaceutical Co (FRA:KOY) has a Growth Rank of 4 as of Sep. 05, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Kobayashi Pharmaceutical Co and its competitors. This is 43% below median its historical median of 7.00. Over the past decade, Kobayashi Pharmaceutical Co's Growth Rank has ranged from 3.00 to 10.00.
Is Kobayashi Pharmaceutical Co's Growth Rank too high?
Kobayashi Pharmaceutical Co's current Growth Rank of 4 is 43% below median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 10.00. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Growth Rank compare to PG and CL?
Kobayashi Pharmaceutical Co's Growth Rank of 4 can be compared against companies in the Consumer Packaged Goods industry. Historically, Kobayashi Pharmaceutical Co's own Growth Rank has ranged from 3.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Consumer Packaged Goods company?
A good Growth Rank depends on the Consumer Packaged Goods industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Kobayashi Pharmaceutical Co and its competitors. Kobayashi Pharmaceutical Co's current Growth Rank is 4, which is 43% below median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co (FRA:KOY) is currently considered Modestly Overvalued. The stock's GF Value™ is €26.16, compared to a current price of €30.40 — trading 16.2% above its estimated fair value. The current Growth Rank is 4, which is 43% below median its 10-year median of 7.00. Kobayashi Pharmaceutical Co's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (FRA:KOY), the current Growth Rank is 4 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kobayashi Pharmaceutical Co (FRA:KOY) Overvalued in 2026?

Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be overvalued. The current stock price of €30.40 is trading 16.2% above its estimated GF Value™ of €26.16. GuruFocus considers Kobayashi Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for FRA:KOY:

  • Growth Rank: 4 (43% below median its 10-year median of 7.00)
  • GF Value™: €26.16 vs. price of €30.40 (16.2% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the FRA:KOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kobayashi Pharmaceutical Co Business Description

Other Exchanges 4967:Japan
Address 4-4-10 Doshomachi, KDX Kobayashi Doshomachi Building, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
77GF Score

Get the complete analysis for FRA:KOY

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€30.40
Price
€26.16
GF Value